FDA Import Refusal 1FX-3647338-7/20002/1 — Sanofi-Aventis Deutschland GmbH
The FDA refused shipment 1FX-3647338-7/20002/1 from Sanofi-Aventis Deutschland GmbH (Germany) on Aug 13, 2026. The refused product falls under Drugs and Biologics — INSULIN GLARGINE. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 13, 2026
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 58HCK09 INSULIN GLARGINE
- Charges
- 75